NCT07162155View on ClinicalTrials.gov

A Hybrid Program to Prevent Substance Use Risk Among Upper Elementary School Students Using a Positive Youth Development Approach

NANot yet recruitingINTERVENTIONAL
Enrollment

3,000

Participants

Timeline

Start Date

January 31, 2026

Primary Completion Date

June 30, 2028

Study Completion Date

August 31, 2028

Conditions
VapingE Cig UsePrescription Drug Misuse
Interventions
BEHAVIORAL

School-based Hybrid Intervention to Prevent Vaping and Prescription Drug Misuse

Psychosocial school-based hybrid intervention which includes traditional classroom sessions and online e-learning modules to reduce risk of vaping and prescription drug misuse among upper elementary school students.

Trial Locations (1)

10604

National Health Promotion Associates, White Plains

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Christopher Williams

INDUSTRY

NCT07162155 - A Hybrid Program to Prevent Substance Use Risk Among Upper Elementary School Students Using a Positive Youth Development Approach | Biotech Hunter | Biotech Hunter